Login

Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd 00:00:00

Share On Facebook Share On Twitter

Sienna Cancer Diagnostics, CEO, Matthew Hoskin provides an update

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
D4T4 SOLUTIONS PLC - Post-AGM Q&A | Bill Bruno, CEO, D4t4 Solutions PLCD4T4:LSE
00:10:00
Pay Down Debt or Invest? Expert Advice from Cove Financial Planning | Ben Smith - FOUNDER & FINANCIAL PLANNER of Cove Financial Planning, LLC
00:10:00
Stavely Minerals Achieves High-Grade Copper-Gold Discoveries; Arafura's Nolans Project to Supply Global Market with NdPr Oxide
00:10:00
The Global Venture Market will the VC funding decline stifle innovation|Amy Cheetham,Partner,Costanoa Ventures
00:10:00
Robert Strzelecki on TenderHut's Main Floor Transition and Startups' Market Challenges | Robert Strzelecki, CEO , TenderHut SA.
00:10:00
Navigating ARPA Fund Investments: Insights from the CWI Early Care & Education La Crosse Summit
00:10:00
we have partnered with startups in sectors ranging from e-commerce to Government technology|Alex Rubalcava,Managing Partner,Stage Venture Partners
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
C4X Discovery signs potential $402mln deal - Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding
00:10:00
Sberbank's Pandemic Impact and Future Outlook | Herman Gref, CEO, Sberbank.
00:10:00
ACG Metals CEO Artem Volynets Announces $290 Million Acquisition of Gediktepe Mine | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
Navigating Financial Uncertainty in a Potential Recession with Hyden Ross | Hyden Ross, Director, Pathway Financial Planners.

© 2026 Nehu